Synthesis and biological evaluation of new epalrestat analogues as aldose reductase inhibitors (ARIs)
| Autor: | Sanjay K. Banerjee, Chandrakant Bagul, Mettu Ravinder, Vaidya Jayathirtha Rao, Keerthi Ravikanti, Jagadeesh Babu Nanubolu, Kolupula Srinivas, Pankaj K. Bagul, Thatikonda Narendar Reddy |
|---|---|
| Rok vydání: | 2014 |
| Předmět: |
Pharmacology
Aldose reductase Rhodanine Stereochemistry Organic Chemistry Biological activity General Medicine Crystallography X-Ray Reference drug In vitro Diabetes Complications Molecular Docking Simulation Structure-Activity Relationship chemistry.chemical_compound Biochemistry chemistry Aldehyde Reductase Drug Discovery Humans Thiazolidines Enzyme Inhibitors Epalrestat Biological evaluation |
| Zdroj: | European Journal of Medicinal Chemistry. 71:53-66 |
| ISSN: | 0223-5234 |
| DOI: | 10.1016/j.ejmech.2013.10.043 |
| Popis: | Baylis-Hillman chemistry derived four series of new epalrestat analogues were synthesized. Three structural changes are introduced in these 39 new epalrestat analogues synthesized. All compounds were evaluated for their in vitro aldose reductase inhibitory (ALR) activity. Biological activity data indicates that compounds 6, 16, 19, 28 and 29 are potent and the activity is in the range of reference drug, epalrestat. Molecular modelling studies were performed to understand the binding interactions of these active molecules with the ALR protein. Molecular docking data indicates the key interactions of epalrestat were retained in some of the active compounds whereas some new interactions were noticed for other molecules. The modifications introduced on epalrestat have impact for developing a new-type of ALR inhibitor. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect